Short-term Adverse Events After the Third Dose of the BNT162b2 mRNA COVID-19 Vaccine in Adults 60 Years or Older.

ABSTRACT:

SUBMITTER: Auster O 

PROVIDER: S-EPMC9016488 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature